Literature DB >> 18681931

Reversible splenial lesion syndrome (RESLES): what's in a name?

Juan Carlos Garcia-Monco1, Ines Escalza Cortina, Eva Ferreira, Amaia Martínez, Lara Ruiz, Alberto Cabrera, Marian Gomez Beldarrain.   

Abstract

BACKGROUND: The presence of transient lesions involving the splenium of the corpus callosum (SCC) has been described in patients with encephalitis or encephalopathy of varied etiology. We have termed it RESLES (reversible splenial lesion syndrome).
PURPOSE: To describe 3 additional patients (2 encephalitis, 1 hypoglycemia) and review the literature to define this syndrome, its etiology, presentation, prognosis, and possible pathophysiological mechanisms.
METHODS: Search of the MEDLINE database from 1966 through 2007. English language article titles and abstracts were screened and the appropriate articles reviewed. Additional articles cited by original references were also reviewed.
RESULTS: RESLES is caused by antiepileptic drug withdrawal, infection, high-altitude cerebral edema (HACE), or metabolic disorders (hypoglycemia and hypernatremia). Complete resolution after a variable lapse is the rule. Clinical presentation is nonspecific, without evidence of callosal disconnection syndromes. Neuroimaging shows a nonenhancing, round-shaped lesion centered in the SCC that disappears after a variable lapse. Diffusion studies reveal DW hypersignal with low ADC values, suggestive of cytotoxic edema. Only HACE-related cases and 1 patient with pregabalin withdrawal showed high ADC values, consistent with vasogenic edema.
CONCLUSION: RESLES is a distinct clinicoradiological syndrome of varied etiology and benign course except in those patients with an underlying severe disorder.
Copyright © 2008 by the American Society of Neuroimaging.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 18681931     DOI: 10.1111/j.1552-6569.2008.00279.x

Source DB:  PubMed          Journal:  J Neuroimaging        ISSN: 1051-2284            Impact factor:   2.486


  55 in total

1.  Transient cytotoxic edema caused by hypoglycemia: follow-up diffusion-weighted imaging features.

Authors:  Musa Atay; Ayse Aralasmak; Rasul Sharifov; Rukiye Kilicarslan; Talip Asil; Alpay Alkan
Journal:  Emerg Radiol       Date:  2012-04-14

2.  [Herpes simplex meningitis with splenial lesion].

Authors:  J-D Werner; C Leithner; F Connolly
Journal:  Nervenarzt       Date:  2016-02       Impact factor: 1.214

3.  Reversible splenial lesion and complex visual disturbances due to carbamazepine withdrawal.

Authors:  Rosa Cortese; Giuseppe Pontrelli; Maria Paola Mogavero; Franca Dicuonzo; Carla Tortorella
Journal:  Neurol Sci       Date:  2015-03-13       Impact factor: 3.307

4.  Reversible lesion involving the splenium of the corpus callosum caused by phenytoin sodium withdrawal.

Authors:  Lingling Wang; Xiaoshan Wang; Xiangsong Shi; Wenchao Qiu; Ailiang Miao
Journal:  Neurol Sci       Date:  2016-11-19       Impact factor: 3.307

Review 5.  Reversible splenial lesions presenting in conjunction with febrile illness: a case series and literature review.

Authors:  David Lin; Matthew Rheinboldt
Journal:  Emerg Radiol       Date:  2017-05-18

6.  Reversible lesions of the splenium of the corpus callosum in children - additional evidence from a Caucasian population.

Authors:  Maria Camilla Rossi Espagnet; Andrea Romano; Daniela Longo; Lorenzo Figà-Talamanca
Journal:  Pediatr Radiol       Date:  2018-05-18

7.  Mild encephalopathy with reversible splenial lesion in a patient with influenza A infection--first report in an adult patient in the USA.

Authors:  Jonathan Wang; Earl Stewart; Kwame Dapaah-Afriyie; Arkadiy Finn
Journal:  BMJ Case Rep       Date:  2015-06-02

8.  5-FU-induced leukoencephalopathy with reversible lesion of splenium of corpus callosum in a patient with colorectal cancer.

Authors:  Gyanendra Acharya; Maria T Cruz Carreras; Terry Wynne Rice
Journal:  BMJ Case Rep       Date:  2017-11-21

9.  Mild encephalitis/encephalopathy with a reversible splenial lesion in children.

Authors:  Adalet Elçin Yıldız; Hülya Maraş Genç; Esra Gürkaş; Havva Akmaz Ünlü; İbrahim Halil Öncel; Alev Güven
Journal:  Diagn Interv Radiol       Date:  2018 Mar-Apr       Impact factor: 2.630

10.  Association of reversible splenial lesion syndrome (RESLES) with Anti-VGKC autoantibody syndrome: a case report.

Authors:  Thomas R Gilder; Jason S Hawley; Brett J Theeler
Journal:  Neurol Sci       Date:  2016-01-07       Impact factor: 3.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.